THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF ARTICLE 7 OF REGULATION 2014/596/EU (WHICH FORMS PART OF
DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT
2018 (THE "EUWA")) ("UK MAR"). UPON THE PUBLICATION OF THIS
ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW
CONSIDERED TO BE IN THE PUBLIC DOMAIN.
Brand Architekts Group
plc
("Brand Architekts" or the
"Group")
Final
Results
Brand Architekts Group plc, a market
leader in the development and supply of beauty and personal care
brands, announces its Full Year results to 30 June 2024.
Business highlights:
Strategic focus on fewer, bigger,
solution-led margin accretive brands, rationalising the portfolio
to 8 key focus brands.
· Super
Facialist grew by 17%, fuelled by distribution gains, notably
Holland & Barrett.
· Skinny
Tan's Body Glow
launched into Boots, Superdrug, Asda and Tesco. Body Glow is now
the fastest growing value sku in the UK tanning category (Circana
latest 12 weeks ending 8 July 24).
· Dirty
Works launched in 750 Watsons stores in 9 countries, with
encouraging sell out results. FY25 brand refresh will focus on all
year-round gifting and a sub range called Mood Magic.
· The Solution's net sales were up 43%.
The Solution Menopause range launched on its own website in June
2024 and rolled out to Amazon in July 24. The Solution Haircare
range is planned to launch in Q3 FY25.
· Net sales
of Root Perfect grew +14%, driven by strong UK demand for
affordable hair colourants and a pan European distribution
expansion across Normal stores.
· The number
of live skus across the Group portfolio was reduced by 19% to 248,
whilst net inventory reduced by £1.4m.
Financial Highlights:
· Sales
for FY24 were £17.0m (down 15% on 2023: £20.1m) due to a planned
brand rationalisation programme, as well as challenging trading
conditions in the UK caused by a cost-of-living crisis and an
unseasonably wet spring and early
summer.
· Gross
profit margins increased by 1.5% to 41.2% (2023: 39.7%).
· Underlying operating loss of £0.4m, was £0.8m lower than the
prior year (2023: £1.2m operating loss) - better targeted
advertising & promotions, and the benefit of a full year
of operational synergies.
· The
decreased loss before taxation of £1.4m (2023: £6.8m) reflects a
reduced operating loss of £0.8m, together with a reduction in
exceptional items (Innovaderma goodwill impairment of £3.5m, legal
fees of £0.7m and IDP restructuring costs £0.4m).
· The
Group retains a strong net cash position of £7.0m at the year-end
(30 June 2023: £8.2m). £1.0m outflow for the acquisition of MR
and the resolution of the legal claims & costs relating to the
Fish acquisition in 2018.
|
2024
|
2023
|
Reported results from continuing operations
|
|
|
Revenue (Note 2)
|
£17.0m
|
£20.1m
|
Underlying operating (loss)
1
|
£(0.4)m
|
£(1.2)m
|
Loss before taxation
|
£(1.4)m
|
£(6.8)m
|
Basic (loss)per share
|
(5.2)p
|
(23.5)p
|
Net cash
|
£7.0m
|
£8.2m
|
¹
Underlying operating loss is calculated before
exceptional items, share-based payments and amortisation of
acquisition-related
intangibles.
Quentin Higham, Chief Executive, commented:
"The Group made good progress in
rationalising its portfolio, whilst improving margins and
significantly reducing its underlying operating
losses. We expect to grow our brands
through increased consumer awareness, investment in customer
acquisition campaigns; product productivity; an extensive NPD
pipeline planned for H2; the repositioning of Skinny Tan as Skin
& Tan and international expansion. We will continue to focus on
brand contribution and a further release of working capital tied up
in harvest brands. We remain confident that
the foundations we are building will enable us to return to
profitability and achieve our medium and long-term
goals."
For
further information please contact:
|
|
|
|
|
Brand Architekts Group PLC
Quentin Higham / Geoff
Ellis
|
|
|
Singer Capital Markets
Shaun Dobson / Jen Boorer
|
(Nominated adviser and broker)
|
020 7496 3000
|
Chairman's Statement
The Group continues to successfully
deliver its portfolio rationalisation program and exit
underperforming & unprofitable brands. Whilst this has led to a
15% decline in net sales (£17.0m v FY23 £20.1m) this process is in
line with our strategy to focus on fewer, bigger, solution-led
margin accretive brands. This has allowed us to release working
capital tied up in non-strategic brands allowing us to target
investment into our Invest brands.
A number of our brands saw good
growth this year, with Super Facialist net sales
up 17%; Root Perfect grew 14%; Fish grew by 24% and The
Solution grew by 43%. Despite this the company has faced
well documented, challenging, wider market conditions, in
particular the cost-of-living crisis, severely affected the UK's
premium self-tan category and resulted in double digit decline
across the premium self-tan category. Skinny Tan was adversely
affected in its UK offline and DTC channels, accounting for 42% of
the overall net sales decline. Skinny Tan Net
sales for the year in the UK were down 27%. In H2 the excellent
growth we have seen in Dirty Works sales in Watsons across Asia was
offset by a softening in sales in TJ Maxx so that Dirty Works sales
were down 16%. The exit of underperforming brands & categories
(i.e. Happy Naturals; Kind Natured, Christmas Gift exclusives)
resulted in a £1.1m revenue decline. However, our strategic intent
remains to grow our key Invest and Nurture
brands.
I was pleased that the business has
continued to focus on reducing underlying
operating losses, which reduced from a £1.2m loss last year to a
£0.4 loss in the year under review. The significant improvement on
the prior year, was as a result of improved operational
efficiencies, in particular, more effective use of targeted
advertising and promotions, as well as a continued focus on cost
control with actions taken to reduce staff costs and other
overheads.
Central Plc. costs were reduced by
38% and now account for 15% of the overall group manpower and
overhead costs. This was in part due to the one term benefit of
releasing historical Executive cash
settled LTIPs, but also strong cost
management. I was particularly pleased that April 2023's triennial valuation of the closed defined benefit
pension plan resulted in a significant reduction in the deficit
recovery plan, under which we have a commitment to make payments of
£318,000 per annum until 30th June 2033.
The Group closed the year with net
cash of £7.0m, which although a £1.2m decline year on year,
reflected the £1.0m outflow for the acquisition of MR and the
resolution of the long term historical legal claims and associated
costs.
We remain focused
on realising both the strategic and financial aims of the Group. In
line with our Brand Development strategic tenet, immediate
priorities are on driving brand awareness on Skinny Tan and Super
Facialist, with an expected year-on-year increase in digital
awareness and acquisition campaigns - with more investment in
TikTok and Influencers. This will address rate-of-sale (ROS)
challenges. I am also very excited by the repositioning of Skinny
Tan as Skin & Tan, which will filter through from November 2024
through to Spring 2025.
Historically we have done a very
good job in securing new distribution, but to maintain these
listings requires necessary advertising and promotional (A&P)
spend to generate the appropriate ROS to maintain these listings.
It is therefore vital that we further invest into A&P and work
tirelessly on implementing our brand development strategic tenets.
Good progress has been made on new
product development, brand launches and relaunches and distribution
gains, which are in line with our problem-solving strategy and
therefore gives a degree of confidence for the future.
Key highlights include:
·
Super Facialist grew by
17%, fuelled by distribution gains, in particular in Holland &
Barrett in Q2. The brand's design upgrade started to enter stores
during Q4. Super Facialist's New Vegan Collagen line and New Sleep
Smart Night Moisturisers launched into Boots in July 24.
Significant increase in digital awareness campaigns is planned
throughout the new year to support ROS.
·
In response to market
trends and consumers' switch to more affordable gradual tanners,
Skinny Tan's Body Glow launched into Boots, Superdrug, Asda and
Tesco. As a result, Body Glow sku is now the fastest growing value
sku in the UK tanning category (Circana latest 12 weeks ending 8
July 24). Skinny Tan launched as a Boots exclusive in all its
international stores across six Gulf countries in Q3 and launched
into Morrisons in July 24. The Skin & Tan relaunch strategy has
been well received by existing customers and we have a secured
pipeline of exciting Face Glow NPD planned for the next tanning
season. Targeted Investment will continue to be made into new
aspirational digital assets, and we will be investing into more
digital awareness campaigns throughout the year. We are working
with our American distributor to accelerate growth in the US, and
we are also working with their European arm to launch Skin &
Tan across Amazon Europe.
· Dirty
Works launched in 750 Watsons stores in 9 countries, with very
encouraging sell out results in Thailand, Turkey, Malaysia, the
Gulf, Singapore and Hong Kong. The brand refresh with a focus on
all year-round gifting, the signature range and new products should
lead to further distribution opportunities domestically and
internationally.
· The Solution's net sales were up 43%.
The Solution Menopause range launched on its own
website in June 2024 and rolled out to Amazon in July 24. The range
is succinct; meets important consumer needs- states; has excellent
empirical consumer panelling and encapsulates our company
vision. The Solution Haircare range is
planned to launch in Q3 FY25.
· Net
sales of Root Perfect, a key Harvest brand, continued to outperform
last year +14%, driven by strong UK demand for affordable hair
colourants and a pan European expansion across Normal stores and an
improved pricing strategy in Morrisons. The objective is to
replicate this success with other key European
retailers.
· We have pivoted MR Expert Solutions' route to market, so that
we are focused on building a male problem-solving brand solution
online, rather than offline, this reflects how men prefer to shop.
Investment will be made into creating new digital assets and
investment into Amazon conversion.
We will continue to deliver revenue
synergies through international expansion, retain a laser focus on
brand contribution and release working capital tied up in harvest
brands. We remain committed to returning the business to
profitability at the earliest opportunity.
On behalf of the Board, I would like
to thank our employees for their hard work and commitment and
shareholders for their continued support.
CEO's Statement 2024
We continue to make progress in
increasing brand awareness, relevance, brand and product
productivity, and social and digital presence. We continue to look
at ways to address our over reliance on non-strategic sales
channels; whilst reducing our central corporate costs.
The well documented cost-of-living
crisis affected certain categories more disproportionally than
others. Whilst we benefited from consumers buying into more
affordable hair colourants, which saw Root Perfect net sales grow
by 14%, conversely, the premium self-tan subcategory showed double
digit decline. Given the squeeze on disposable income, consumers
switched from instant premium tanners to more affordable gradual
tanners. This resulted in Skinny Tan's UK sales declining by 27%,
despite the brand extending its global distribution into Latin
America and the Middle East. We also launched Skinny Tan Body Glow
(gradual tanner) into full UK omnichannel distribution in H2, which
resulted in it becoming the fastest growing value sku in the UK
(Circana 12-week July 24).
The ongoing strong performance of
the UK Beauty High Street and the general softening of the
direct-to-consumer market reinforces the need for a strong
omnichannel approach. We continue to work closely with our offline
partners, and I was pleased to see some notable distribution gains
on our key Invest and Nurture brands, in particular the launch of
Super Facialist into Holland & Barrett and Skinny Tan Body Glow
distribution gains across the UK. The focus for our DTC channels
has been on improving profitability and ROAS (return on advertising
spend), whilst investing in brand content and assets so that we can
improve the overall immersive DTC brand experience.
Over the next 12 months we have a
strong brand development program in place, with several exciting
product launches (Super Facialist and Skinny Tan), brand redesigns
(Super Facialist and Dirty Works); brand extensions (The Solution
Menopause and Haircare), and the relaunch of Skinny Tan as Skin
& Tan in 2025. We are excited by our key customers and
consumers response to the Skin & Tan relaunch strategy and are
confident that this will enable the brand to increase its relevance
and saliency. We are also optimistic that the new face-centric
skincare enhanced products will bring new consumers to the brand
and to the category.
Performance review
The 27% softening of Skinny Tan
across the UK trade had an adverse effect on all channels, in
particular Boots and DTC, with the exception of Amazon where Skinny
Tan grew by 19%. However, Skinny Tan was able to grow its
international business with new listings in the Middle East and
Peru. Rationalisation of the portfolio and the exiting of three
underperforming brands also affected the overall UK business.
Amazon was the standout channel with sales up 27%. Our
business in the USA General Merchandise discount channel declined
by 34%, as we took strategic steps to focus on the core portfolio.
We were however pleased that the remaining Export business grew
63%. This was driven by strong Dirty Works distribution gains
across 750 Watsons stores which helped Dirty Works grow by 71% in
this channel. We are over one year into our strategy of
rationalising our portfolio and focusing on problem solving, margin
accretive brands and this is beginning to show through. Our number
one performance priority is to continue to address ROS challenges
and invest in topline sales growth for our key Invest and Nurture
brands.
Gross Profit margin increased by
1.5ppts to 41%, with Dirty Works +6ppts, Mr Expert Solutions
+13ppts and Dr Salts +17ppts. These offset the decline from the
Skinny Tan revenue reduction, which affected the overall margin mix
of the business. This reflects our drive to improve margins and
long-term profitability.
Whilst sales performance was
disappointing, the business worked very hard in reducing its
losses. The underlying operating loss improved by £0.8m to show a
loss for the year of £0.4m. This was driven by £0.4m reduction in
central costs, notably the release of executive LTIP accruals and a
reduction in executive manpower costs. We made £0.4m savings in
overheads driven by IDP acquisition synergies.
Progress made against the Group's
three strategic pillars is outlined below:
1. Brand Development
By the end of FY25 the objective is
to rationalise the brand portfolio down to 8 brands, split into 3
classifications: Invest, Nurture and Harvest.
Skinny Tan and Super Facialist are
classified as Invest Brands. They have an omnichannel route to
market including their own DTC site; masstige positioning; a degree
of existing scale as demonstrated through net sales and market
share, and both have significant growth potential through A&P
investment focusing on digital brand awareness and conversion
campaigns. In response to market research, we will be relaunching
Skinny Tan as Skin & Tan in FY25. This is a major and exciting
initiative, which along with a pipeline of exciting new face tan
products, will help deliver sustainable and long-term growth and
address the declines of the last two years.
Dirty Works, The Solution and MR
Expert Solutions are classified as Nurture brands. Dirty Works has
the potential to broaden its presence through new category
extensions, such as All Year-Round Gifting, to new distribution
gains through international partners, such as Watsons. The Solution
and MR are both high-performance propositions, with a clear point
of difference that answer the specific needs of the consumer. Our
initial focus is on developing The Solution brand by launching a
highly efficacious and targeted sub brand called The Solution
Menopause. This launched on Amazon and its own DTC site in June 24.
Our focus this financial year will be on extending the Menopause
distribution to other key retailers and then by introducing The
Solution Haircare range. Our vision is for The Solution to become a
master brand that provides focused personal care
solutions.
Although we discontinued three
brands last year, we will be exiting a further two (SenSpa and
Argan+) in FY25, which will leave a portfolio of three low
investment Harvest Brands. These brands, such as Root Perfect,
require minimal investment, they compete on price and provide us
with a stronger category share of voice and credibility with key
customers. Fish, which was upgraded with new packaging in 2024, has
the potential to become a Nurture brand, once its brand reach has
been increased. Charles + Lee, which is an Australian centric male
grooming brand, has a strong gifting proposition and top 4 position
in the Australian department store channel.
The following strategic Brand
Development tenets have been applied to our Invest and Nurture
brands:
Profitability
With a sharp focus on brand
contribution, our A&P spend is focused on our Invest brands. We
continually evaluate our packaging footprint in line with our
sustainability pledge and where possible remove all secondary
packaging to reduce costs. In addition, we implement VRE (value
reengineering) initiatives to reduce COG (cost of goods), so as to
improve every brand's Gross Profit, whilst retaining high product
quality. One such initiative is the VRE of the Root Perfect cans,
which resulted in a double-digit Gross Profit improvement at the
latter end of last year.
The business continues to review its
range offering and where possible we rationalise ranges to remove
duplication and improve sku productivity and profitability. Last
year the number of live skus was reduced by 19% to 248. Along with
prudent stock management, we were able to reduce our net inventory
by £1.4m. As part of the Skin & Tan relaunch planned for the
next fiscal, we will be reducing the range by 41% to 24
skus.
NPD/Consumer Insights
Towards the end of FY24 H2, Super
Facialist launched a new Vegan Collagen range and a range of new
Night Moisturisers.
Vegan Collagen is an innovative,
easy-to-navigate line up of ingredient-led, solution-driven
formulas including a cleanser, serum, day cream and night cream.
Blending a potent Marine Biopolymer made from sustainably sourced
Red Algae and Hyaluronic Acid, with plant-derived Vegan Collagen
sourced from the sap of the acacia tree. Collagen is a trending
ingredient which responds to the growing demand for
age-preventative skincare, presenting an opportunity to provide
customers with an affordable trade-down collagen solution that's
vegan-friendly. It delivers both immediate and sustained hydration
to the skin, targeting signs of ageing to reveal a plumper and
smoother complexion. The Vegan Collagen line launched in Boots,
Amazon and DTC at end of the year.
After three years of research and
development Super Facialist launched a range of Sleep Smart Night
Creams across our bestselling ranges, Rosehip, Retinol and Vitamin
C. This "World first" Resync SleepSmartâ„¢ Complex technology is
powered by two potent & proven actives. It is a revolutionary
concept that helps reset & rejuvenate skin overnight when
skin is its most receptive to repair. The formulation works
in synchronisation with the skin's circadian rhythm for a refreshed
& healthier looking complexion. The new moisturisers started to
filter through into store across all retailers in Q4.
In response to the cost-of-living
crisis the new Skinny Tan Body Glow Gradual Tanner launched across
all UK channels and became the fastest growing tanning value sku in
the UK. On the back of extensive consumer research, we will
be relaunching Skinny Tan in FY25. We expect the relaunch to
facilitate new customer acquisition, expand our press reach and
increase the scope for new brand listings domestically and
internationally. Relaunching as Skin & Tan is a simple name and
logo change, but one that encapsulates our vision, where everybody
can radiate confidence and have a healthy glow. Skin & Tan is
an inclusive name that clearly demonstrates our expertise and
enables easier category, retailer and market expansion. In response
to consumer demand, we will be expanding our Face Tan products,
which will be launching in time for the new 2025 tanning season.
The three new products will all retail at the emotive and
competitive £20 price point, and they all include the registered
Oxygeskin complex, that allows oxygen to strengthen the skin's
barrier functions, whilst improving skin quality. The new sub
range includes a Deep Hydration Sleepover Tan Mask, a Hydrating
Tanning Mist; and a Hydrating SPF Tanning Serum, which combines
superior tanning technology with a multi-molecular hydration
complex and a broad SPF protection.
To maintain momentum and consumer
engagement, design upgrades for Super Facialist, MR Expert
Solutions and Dirty Works will filter throughout FY25.
Digital 1st
Last year we restructured the team
to better leverage resources and have significantly increased
digital activity across all commercial and media channels.
Performance marketing has been brought inhouse, thereby enabling us
to execute more paid activity across Google, YouTube, TikTok, Meta
and Affiliation, which helps drive consumers to D2C, Amazon and
offline retailers. We have shifted a higher portion of the
media spend and organic activity to TikTok and launched TikTok
shops. Given the growing importance of first party
data/direct consumer touch, we have increased the focus on building
social following and grown the number of engaged customers in our
email/SMS databases, whilst also removing unengaged customers. The
Skinny Tan database engagement grew from 32% to 81% post the
cleansing of the database, which reduced from 340k to 180k. We have
started involving brand fans more in content creation and product
development. We continue to launch products first on D2C and
Amazon, in order to quickly build 5-star reviews before launching
in other channels, but also to make sure that our loyal database
consumers are rewarded first.
Advertising & promotions (A&P)
A&P spend is focused on Skinny
Tan and Super Facialist, both brands benefit from a retained PR
agency; appointed skincare & tanning experts; substantial
campaign activity across Google, YouTube, TikTok, Meta and retail
specific activation.
Last year we supported Super
Facialist with a strong "Vitamin C + Me" campaign and the focus for
the next year is to significantly grow brand awareness and foster
engagement with both new and existing consumers, through 360
omnichannel campaigns that deliver extensive reach, provide
disruptive brand content, whilst being supported with PR and
influencer campaigns. Digital activity will be focused on the new
Rosehip Double Cleanser launch in Boots in the summer; Vegan
Collagen and Sleep Smart activity in the Autumn, whilst our main
campaign will be focused on supporting the launch of Super
Facialist Vitamin C SPF 50 Serum in Spring 2025.
Last year Skinny Tan's Wonder Serum
awareness and conversion campaign was adversely affected by overall
category dynamics, in particular consumer confidence, level of
discretionary spend and a change in consumption behaviour. The
focus for this fiscal is on addressing omnichannel brand awareness
and we will be putting higher media investment into broader and
more effective channel targeting and fully integrated omnichannel
activation, in order to reengage existing customers and reach new
audiences. We will continue to invest into conversion, which will
be optimized around key retailer and promotional moments.
Investment will also go into a website relaunch; asset upgrades;
organic social activity and a PR campaign to support the relaunch
and extended distribution of the Body Glow franchise and the launch
of Skin & Tan Face Glow.
2. Brand Reach
We believe in an omnichannel
distribution approach, to ensure that our customers can buy our
brands and products whenever, wherever and on whatever they want.
It is therefore imperative that we build our brand distribution
online and offline, whilst supporting our key Invest brands with
their own DTC sites.
UK
& International
Last year we launched Super
Facialist into Holland & Barrett and The Solution into
Waitrose. Dirty Works rolled out to 750 Watsons stores in 9
countries in the Middle East and Asia. Skinny Tan Body Glow
launched in Boots, Superdrug, Asda, Tesco and also in Peru and 6
Gulf countries. The brand launched into 327 Morrisons stores in
July 2024 and we are aiming to expand distribution throughout the
UK and Internationally on the back of the forthcoming relaunch and
exciting NPD. We plan to appoint an Australian distributor to
manage Skin & Tan DTC and on Amazon Australia, in time for the
Winter tanning season (like our new American model). This will
enable us to close the Skinny Tan Australian entity and further
simplify our business. We launched The Solution Menopause on Amazon
in July 2024 and expect to secure distribution gains across the
three pillars of the brand in the second half of the fiscal.
Participation at Cosmoprof Bologna in March will be key to securing
international distribution for The Solution franchise. Our
objective with Super Facialist is to consolidate existing UK
distribution and focus on improving ROS and productivity. We are
attending several ECRM International Trade shows to secure new
distribution in H2.
D2C
Our focus for the Skinny Tan D2C
site has been on profitability and to align pricing and promotions
across all channels. Strategy for last year and the new fiscal is
to shift spend from D2C conversion to omnichannel awareness and
conversion. A more selective conversion advertising approach
improved D2C ROAS FY24 6.0 v FY23 4.4. However, the overall low
demand and our omnichannel approach of matching promotions and
offers across all channels, resulted in last year's disappointing
but expected DTC net sales decline. All tech stack contracts were
renegotiated with savings achieved across the brands. In June 2024
we launched The Solution D2C site, which is integral to building
awareness and trial of the new Menopause range. Traffic and database growth programmes will build slowly,
since brand A&P will be focused on omnichannel brand awareness.
Our strategy for Super Facialist DTC is for the site and database
to grow organically on the back of increased traffic through the
wider omnichannel awareness campaigns, rather than aggressive
conversion investment. The site is steadily growing month on month,
and we have further improved profitability by moving to a more cost
effective 3PL.
3. Sustainability
99% of our single products are fully
recyclable or reusable. 60% of our plastic packaging includes post
recycled materials, with this figure reaching 90% for all tubes.
100% of our UK-sourced cartons have Forest Stewardship
Council (FSC) certification, reflecting our commitment to work
in an environmentally responsible manner whenever possible. We have
also started using Prevented Ocean Plasticâ„¢ (recycled plastic
collected from coastal areas at risk of plastic pollution) in some
of our key brands such Super Facialist, Dirty Works and Fish to
actively prevent ocean plastic and further support sustainable
initiatives.
Outlook
The management team
remains focused on continuing to realise both the strategic and
financial aims of the Group. In line with its Brand Development
strategic tenet, immediate priorities are launching an extensive
new product development pipeline planned for H2 and supported by
extensive consumer research, the repositioning of Skinny Tan as
Skin & Tan, which will filter through in 2025. We will be
supporting this by driving brand awareness on Super Facialist and
Skinny Tan, with an expected year-on-year increase in digital
awareness and customer acquisition campaigns - with targeted
investment in Tik Tok and Influencer marketing.
We expect to deliver revenue growth
through an improvement in consumer awareness, product productivity,
NPD pipeline and through international expansion. We will retain a
keen focus on brand contribution and will further release working
capital tied up in harvest brands or discontinued products.
We remain confident that the foundations we
are building will enable us to return to profitability and achieve
our medium and long-term goals.
Financial Review
Key performance
indicators
To measure and monitor our progress
against our growth strategy, we track our performance against a set
of ambitious targets and milestones. The goals we set are closely
assessed to ensure we focus our efforts to deliver both in the
short term and long term. A summary of the financial measures used
are:
|
2024
|
2023
|
Reported results from continuing operations
|
|
|
Revenue (Note 2)
|
£17.0m
|
£20.1m
|
Underlying operating
loss1
|
£(0.4)m
|
£(1.2)m
|
Loss before taxation
|
£(1.4)m
|
£(6.8)m
|
Basic loss/earnings per
share
|
(5.2)p
|
(23.5)p
|
Net cash
|
£7.0m
|
£8.2m
|
1
Underlying operating (loss) is calculated before exceptional items,
share-based payments and amortisation of acquisition-related
intangibles.
A reconciliation of underlying
operating loss to operating loss is shown below:
|
2024
Total
|
2023
Total
|
Underlying loss from
operations
|
(412)
|
(1,206)
|
Amortisation of acquisition-related
intangibles
|
(975)
|
(1,027)
|
(Charge)/credit for share-based
payments
|
(26)
|
12
|
Exceptional items - Impairment of
intangible
assets
|
-
|
(3,500)
|
Other exceptional items
|
(133)
|
(1,078)
|
Operating loss
|
(1,546)
|
(6,799)
|
The Group implements a number of
non-statutory measures which are summarised in the tables above and
in more detail within the segmental income statement (Note 2 of the
financial statements). Exceptional items are also explained further
below and in Note 3 of the financial statements. These measures are
used to illustrate the impact of non-recurring and non-trading
items on the Group's financial results.
In addition to the financial key
performance measures, a range of operational non-financial key
performance indicators are also monitored at a management level
covering, amongst others, new product development and innovation.
The Board receives an overview of these as part of its Board
management report.
Statement of comprehensive income
Group statutory revenue for the year
was £17.0m (FY 2023: £20.1m), a decrease of 15% on the prior year
due to a mix of factors. Sales reduced due to the planned brand
rationalisation programme, fewer Christmas gift exclusives and
challenging trading conditions in the UK caused by a cost of living
crisis and an unseasonably wet spring and early summer.
International sales were down £0.5m on the previous
year.
The gross profit margin was better
than the prior year, increasing by 1.5% to 41.2% (2023: 39.7%).
This is due to improved sales mix. Margins from the sale of Brand
Architekts' brand products have been maintained despite continued
and significant cost increases throughout the supply chain, notably
in raw materials, componentry and energy. Cost increases were
passed on to retailers where possible and given previously agreed
pricing commitments.
Despite the challenging trading
environment, the Group generated a reduced operating loss in H2, a
significant improvement on the performance in H1, due to a focus on
better targeted advertising & promotions resulting in improved
contribution.
The Group made a loss before tax of
£1.4m after amortisation of intangibles £1m, and exceptional items
of £0.13m which included restructuring costs (£0.09m), and costs
associated with the resolution of the legal claim with MR haircare
(£0.03m).
Financing costs were £0.1m (2023:
£0.1m) relating to the defined benefit pension plan notional
finance charge.
The effective tax rate for the
period was negative 4% (2023: negative 3%) of pre-tax losses. The
effective rate is below the statutory rate of 25.0% due to the
losses in the period.
Financial position and cash flow
The Group retains a net cash
position of £7.0m, a reduction of £1.2m versus the prior year
(2023: £8.2m). The cash outflow was due to a mix of the underlying
operating loss of £0.4m and the acquisition of the remaining 49%
issued share capital of MR Haircare Ltd for £0.5m. The Company also
made a payment of £0.3m, its annual payment commitment to its
defined benefit pension scheme as outlined below.
Defined benefit pension plan
The defined benefit pension plan
underwent its latest triennial valuation on 5 April 2023. The
scheme funding at this date revealed a deficit of £4.6m. As a
result, the Group entered a revised deficit recovery plan and
schedule of contributions under which there is a commitment to pay
£318k per annum for the ten years to 30 June 2033 and to pay
certain administration costs and the PPF levy for the life of the
plan.
Accounting standards require the
discount rate used for valuations under IAS 19 'Employee Benefits'
to be based on yields on high quality (usually AA-rated) corporate
bonds of appropriate currency, taking into account the term of the
relevant pension plan's liabilities. Corporate bond indices are
used as a proxy to determine the discount rate. In 2023 market
conditions were volatile, there has been some stability in 2024. At
the reporting date, the yields on bonds of all types were
marginally more favourable than the prior year and has resulted in
a slightly more favourable discount rate being adopted for
accounting purposes. The fair value of the plan assets as measured
under IAS 19 has increased year on year at the same time that the
fair value of the scheme's liabilities has decreased, the net
result is a decreased liability under the IAS 19 methodology. For
accounting purposes at 30 June 2024, the Group showed an
unrecognised surplus of £0.8m under IAS 19. (2023: net liability
£1.6m).
Going concern
As part of its normal business
practice, the Group prepares annual and longer-term plans and, in
reviewing this information the directors have a reasonable
expectation that the Company and Group have adequate resources to
continue in operational existence for the foreseeable future. The
Group has significant cash reserves of £7.0m. Accordingly, we
continue to adopt the going concern basis in preparing the Annual
Report and Accounts.
Group Statement of Comprehensive
Income
For the year ended 30 June 2024 and
30 June 2023
|
|
2024
|
2023
|
|
|
Notes
|
£'000
|
£'000
|
|
Revenue
|
2
|
17,027
|
20,085
|
|
Cost of sales
|
|
(10,008)
|
(12,101)
|
|
Gross profit
|
|
7,019
|
7,984
|
|
Commercial and administrative
costs
|
|
(8,431)
|
(10,202)
|
|
Operating loss before exceptional items
|
(1,412)
|
(2,218)
|
|
Exceptional items - Impairment of
intangible assets
|
3
|
-
|
(3,500)
|
|
Other exceptional items
|
3
|
(133)
|
(1,078)
|
|
Operating loss
|
|
(1,545)
|
(6,796)
|
|
Finance income
|
|
173
|
111
|
|
Finance expense
|
|
(74)
|
(88)
|
|
Loss
before taxation
|
4
|
(1,446)
|
(6,773)
|
|
Taxation
|
5
|
56
|
188
|
|
Loss
for the year
|
|
(1,390)
|
(6,585)
|
|
Other comprehensive income:
|
|
|
|
|
Items that will not be reclassified subsequently to profit or
loss:
|
|
|
|
|
Re-measurement of defined benefit
liability
|
|
1,031
|
444
|
|
Other comprehensive income for the year
|
|
1,031
|
444
|
|
Total comprehensive income for the year
|
|
(359)
|
(6,141)
|
|
|
|
|
|
|
Loss
attributable to:
|
|
|
|
|
Equity shareholders
|
|
(1,456)
|
(6,588)
|
|
Non-controlling interests
|
|
66
|
3
|
|
|
|
|
|
|
Total comprehensive income attributable to:
|
|
|
|
|
Equity shareholders
|
|
(425)
|
(6,144)
|
|
Non-controlling interests
|
|
66
|
3
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share
|
6
|
|
|
|
- basic
|
|
(5.2)p
|
(23.5)p
|
|
- diluted
|
|
(5.2)p
|
(23.5)p
|
|
|
|
|
|
|
Dividends
|
|
|
|
|
Paid in year (£'000)
|
|
Nil
|
Nil
|
|
Paid in year (pence per
share)
|
|
Nil
|
Nil
|
|
Proposed (£'000)
|
|
Nil
|
Nil
|
|
Proposed (pence per share)
|
|
Nil
|
Nil
|
|
Group Statement of Financial Position
As at 30 June 2024
|
|
2024
|
2023
|
|
Notes
|
£'000
|
£'000
|
ASSETS
|
|
|
|
Non-current assets
|
|
|
|
Property, plant and equipment
including right of use assets
|
|
29
|
43
|
Intangible assets
|
7
|
13,432
|
14,462
|
Deferred tax assets
|
|
-
|
520
|
Total non-current assets
|
|
13,461
|
15,025
|
Current assets
|
|
|
|
Inventories
|
|
4,718
|
6,123
|
Trade and other
receivables
|
|
4,794
|
4,774
|
Cash and cash equivalents
|
|
6,963
|
8,177
|
Total current assets
|
|
16,475
|
19,074
|
Total assets
|
|
29,936
|
34,099
|
|
|
|
|
LIABILITIES
|
|
|
|
Current liabilities
|
|
|
|
Trade and other payables
|
|
3,250
|
4,687
|
Current Tax Payable
|
|
2
|
2
|
Total current liabilities
|
|
3,252
|
4,689
|
Non-current liabilities
|
|
|
|
Post-retirement benefit
obligations
|
|
-
|
1,619
|
Deferred tax liabilities
|
|
1,952
|
2,190
|
Total non-current liabilities
|
|
1,952
|
3,809
|
Total liabilities
|
|
5,204
|
8,498
|
Net
assets
|
|
24,732
|
25,601
|
|
|
|
|
EQUITY
|
|
|
|
Share capital
|
|
1,397
|
1,397
|
Share premium
|
|
11,987
|
11,987
|
Merger reserve
|
|
6,588
|
6,588
|
Retained earnings
|
|
4,760
|
5,398
|
Equity attributable to holders of the parent
|
|
24,732
|
25,370
|
Non-controlling interest
|
|
-
|
231
|
Total equity
|
|
24,732
|
25,601
|
Group Statement of Changes in Equity
For the year ended 30 June 2024 and
the year ended 30 June 2023
|
|
Share
Capital
|
Share
Premium
|
Merger
Reserve
|
Retained
Earnings
|
Non-controlling
interest
|
Total
Equity
|
|
Group
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
|
Balance as at June 2023
|
1,397
|
11,987
|
6,588
|
5,398
|
231
|
25,601
|
|
Non-controlling interest
|
-
|
-
|
-
|
-
|
66
|
66
|
|
Share based payments
|
-
|
-
|
-
|
26
|
-
|
26
|
Purchase of remaining NCI
shares
|
-
|
-
|
-
|
(239)
|
(297)
|
(536)
|
|
Transactions with owners
|
-
|
-
|
-
|
(213)
|
(231)
|
(444)
|
|
Loss for the year attributable to
equity shareholders
|
-
|
-
|
-
|
(1,456)
|
-
|
(1,456)
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
Re-measurement of defined benefit
liability
|
-
|
-
|
-
|
1,031
|
-
|
1,031
|
|
Total comprehensive income for the
year
|
-
|
-
|
-
|
(425)
|
-
|
(425)
|
|
Balance as at June 2024
|
1,397
|
11,987
|
6,588
|
4,760
|
-
|
24,732
|
|
|
|
|
|
|
|
|
|
Share
Capital
|
Share
Premium
|
Merger
Reserve
|
Retained
Earnings
|
Non-controlling
interest
|
Total
Equity
|
Group
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Balance as at June 2022
|
1,397
|
11,987
|
6,588
|
11,554
|
228
|
31,754
|
Non-controlling interest
|
-
|
-
|
-
|
-
|
3
|
3
|
Share based payments
|
-
|
-
|
-
|
(12)
|
-
|
(12)
|
Transactions with owners
|
|
-
|
-
|
(12)
|
3
|
(9)
|
Loss for the year attributable to
equity shareholders
|
-
|
-
|
-
|
(6,588)
|
-
|
(6,588)
|
Other comprehensive income:
|
|
|
|
|
|
|
Re-measurement of defined benefit
liability
|
-
|
-
|
-
|
444
|
-
|
444
|
Total comprehensive income for the
year
|
-
|
-
|
-
|
(6,144)
|
-
|
(6,144)
|
Balance as at June 2023
|
1,397
|
11,987
|
6,588
|
5,398
|
231
|
25,601
|
Cash Flow Statement
For the year ended 30 June 2024 and
the year ended 30 June 2023
|
Group
|
Company
|
|
2024
|
2023
|
2024
|
2023
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Cash
flow from operating activities
|
|
|
|
|
Loss before taxation
|
(1,446)
|
(6,773)
|
(6,311)
|
(5,493)
|
Depreciation
|
33
|
32
|
-
|
-
|
Amortisation
|
1,054
|
1,118
|
23
|
74
|
Impairment of property, plant &
equipment
|
-
|
(166)
|
-
|
-
|
Impairment of intangible
assets
|
-
|
3,500
|
-
|
-
|
Impairment of investments
|
-
|
-
|
3,600
|
3,500
|
Finance income
|
(173)
|
(111)
|
(161)
|
(111)
|
Finance cost
|
74
|
88
|
74
|
88
|
(Increase)/ Decrease in
inventories
|
1,405
|
1,252
|
-
|
-
|
Decrease /(Increase) in trade and
other receivables
|
(20)
|
325
|
2,075
|
(904)
|
Increase / (Decrease) in trade and
other payables
|
(1,442)
|
(2,082)
|
(829)
|
(996)
|
Share based payment
expense
|
26
|
(14)
|
8
|
(23)
|
Contributions to defined benefit
plans
|
(318)
|
(318)
|
(318)
|
(318)
|
Cash
outflow from operations
|
(807)
|
(3,149)
|
(1,839)
|
(4,183)
|
Taxation received
|
-
|
(66)
|
-
|
-
|
Net
cash outflow from operating activities
|
(807)
|
(3,215)
|
(1,839)
|
(4,183)
|
Cash
flow from investing activities
|
|
|
|
|
Purchase of property, plant and
equipment
|
(19)
|
(22)
|
-
|
-
|
Purchase of intangible
assets
|
(24)
|
(44)
|
-
|
-
|
Cash consideration paid for
acquisitions
|
(537)
|
-
|
(537)
|
-
|
Net
cash flow from investing activities
|
(580)
|
(66)
|
-
|
-
|
Cash
flow from financing activities
|
|
|
|
|
Finance income received
|
173
|
111
|
161
|
111
|
Net
cash flow from financing activities
|
173
|
111
|
161
|
111
|
Net
decrease in cash and cash equivalents
|
(1,214)
|
(3,170)
|
(2,215)
|
(4,072)
|
Cash
and cash equivalents at beginning of year
|
8,177
|
11,347
|
5,730
|
9,802
|
Cash
and cash equivalents at end of year
|
6,963
|
8,177
|
3,515
|
5,730
|
Notes to the Accounts
The financial information does not
constitute statutory accounts as defined in section 435 of the
Companies Act 2006, but has been extracted from the statutory
accounts for the period ended June 2024 on which an unqualified
audit report has been issued and which will be delivered to the
Registrar following their adoption at the Annual General
Meeting. The statutory accounts for the period ended June
2023 have been delivered to the Registrar of Companies with an
unqualified audit report and did not contain a statement under
section 498 of the Companies Act 2006. Copies of the 2024 Annual
Report and Accounts with the notice of Annual General Meeting will
be sent to shareholders via their elected channel. Further copies
may be obtained by contacting the Company Secretary at Brand
Architekts Group plc, 8 Waldegrave Rd, Teddington, TW11 8GT. An
electronic copy will be available on the Group's web site
(www.brandarchitektsplc.com).
Note 1
Significant accounting policies
General Information
Brand Architekts Group plc is a
public limited company which is listed on AIM and is incorporated
in the United Kingdom under the Companies Act 2006. The
address of the registered office is given at the end of the
financial report. The nature of the Group's operations and its
principal activities are set out in the Strategic Report.
The results for the current period have been drawn
up for a traditional 12 month calendar year.
Basis of preparation
The Group has prepared its
consolidated financial statements in accordance with UK adopted
International Accounting Standards (UK adopted IAS) in conformity
with the requirements of the Companies Act 2006. These
financial statements have been prepared under the historical cost
convention.
The Directors have considered
trading and cash flow forecasts prepared for the Group, and based
on these, and the level of cash held, are satisfied that the Group
will continue to be able to meet its liabilities as they fall due
for at least one year from the date of signing of these accounts.
In making this assessment directors have considered the possible
impact of a reduction of trading on budgets and have stress tested
the figures by comparing costs committed to with the cash available
which showed sufficient headroom to continue trading. On this
basis, they consider it appropriate to adopt the going concern
basis in the preparation of these accounts.
The consolidated financial
statements are presented in sterling and all values are rounded to
the nearest thousand (£'000) except where otherwise
indicated.
Basis of consolidation
The Group financial statements
consolidate the financial statements of the Company and its
subsidiary undertakings. The results and net assets of
undertakings acquired or disposed of during a financial year are
included in the Group Statement of Comprehensive Income and
Group Statement of Financial Position from the
effective date of acquisition or to the effective date of
disposal. Subsidiary undertakings have been consolidated
using the acquisition method of accounting. In accordance with the
exemptions given by section 408 of the Companies Act 2006, the
Company has not presented its own Statement of Comprehensive
Income. The Company's loss after tax for the year to June
2024 was £6.479m (2023: loss after tax £5.529m).
The Group financial statements
consolidate those of the parent company and all of its subsidiaries
as of 30 June 2024. The parent controls a subsidiary if it is
exposed, or has rights, to variable returns from its involvement
with the subsidiary and has the ability to affect those returns
through its power over the subsidiary. All subsidiaries have a
reporting date of 30 June.
All transactions and balances
between Group companies are eliminated on consolidation, including
unrealised gains and losses on transactions between Group
companies. Amounts reported in the financial statements of
subsidiaries have been adjusted where necessary to ensure
consistency with the accounting policies adopted by the
Group.
Profit or loss and other
comprehensive income of subsidiaries acquired or disposed of during
the year are recognised from the effective date of acquisition, or
up to the effective date of disposal, as applicable.
Note 2 Segmental
Analysis
During the year, there were three
reportable segments of the Group, the reportable segments of the
Group were aggregated as follows:
· Brand
Architekts Brands - These include those brands organically
developed plus the acquisitions of the portfolio of Brands included
in The Brand Architekts acquisition (in 2016) and the Fish brand
acquired during 2018.
· Innovaderma Brands - This segment includes those brands
acquired as part of the Innovaderma business combination. The
results of Innovaderma brands are currently reported separately
from other brands to the directors.
· Eliminations and Central Costs. Other Group-wide activities
and expenses, including defined benefit pension costs, share-based
payment expenses / (credits), amortisation of acquisition-related
intangibles, interest, taxation and eliminations of intersegment
items, are presented within 'Eliminations and central
costs'.
This is the basis on which the Group
presents its operating results to the Directors, which is
considered to be the Chief Operating Decision Maker (CODM) for the
purposes of IFRS 8. Comparative full year numbers have been
presented on the same basis.
IFRS15 requires the disaggregation
of revenue into categories that depict how the nature, timing,
amount and uncertainty of revenue and cash flows are affected by
economic factors. The directors have considered how the Group's
revenue might be disaggregated in order to meet the requirements of
IFRS15 and has concluded that the activity and geographical
segmentation disclosures set out below represent the most
appropriate categories of disaggregation.
a) Principal
measures of profit and loss - Income Statement segmental
information for year ended 30 June 2024 and year ended 30 June
2023:
Year
ended 30 June 2024
|
Brand Architekt
Brands
|
Innovaderma
Brands
|
Eliminations and
Central Costs
|
Total
|
|
|
£'000
|
£'000
|
£'000
|
£'000
|
UK revenue
|
10,592
|
2,698
|
-
|
13,290
|
International revenue
|
3,280
|
457
|
-
|
3,737
|
Revenue - External
|
13,872
|
3,155
|
-
|
17,027
|
Total Revenue
|
13,872
|
3,155
|
-
|
17,027
|
Underlying profit / (loss) from operations
|
457
|
(147)
|
(721)
|
(411)
|
Charge for share-based
payments
|
(18)
|
-
|
(8)
|
(26)
|
Amortisation of acquisition-related
intangibles
|
-
|
-
|
(975)
|
(975)
|
Other Exceptional items (Note
3)
|
(83)
|
(25)
|
(25)
|
(133)
|
Net borrowing income
|
10
|
2
|
87
|
99
|
Profit / (Loss) before taxation
|
366
|
(170)
|
(1,642)
|
(1,446)
|
Tax charge
|
-
|
(20)
|
76
|
56
|
Profit/(Loss) for the year
|
366
|
(190)
|
(1,566)
|
(1,390)
|
Year
ended 30 June 2023
|
Brand Architekt
Brands
|
|
Eliminations and Central
Costs
|
|
Innovaderma
Brands
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
UK revenue
|
11,243
|
4,538
|
-
|
15,781
|
International revenue
|
3,225
|
1,079
|
-
|
4,304
|
Revenue - External
|
14,468
|
5,617
|
-
|
20,085
|
Total Revenue
|
14,468
|
5,617
|
-
|
20,085
|
Underlying profit/(loss) from operations
|
193
|
(233)
|
(1,166)
|
(1,206)
|
Credit / (charge) for share-based
payments
|
(12)
|
-
|
24
|
12
|
Amortisation of acquisition-related
intangibles
|
-
|
-
|
(1,027)
|
(1,027)
|
Exceptional items - Impairment of
intangible assets (Note 3)
|
-
|
(3,500)
|
-
|
(3,500)
|
Other Exceptional items (Note
3)
Net borrowing income
|
(147)
-
|
(297)
-
|
(634)
26
|
(1,078)
26
|
Profit/(Loss) before taxation
|
34
|
(4,030)
|
(2,777)
|
(6,773)
|
Tax charge
|
77
|
(91)
|
202
|
188
|
Profit/(Loss) for the period
|
111
|
(4,121)
|
(2,575)
|
(6,585)
|
The segmental Income Statement
disclosures are measured in accordance with the Group's accounting
policies as set out in note 1.
All defined benefit pension costs
and an element of the share-based payment expenses are recognised
for internal reporting to the CODM as part of Group-wide activities
and are included within 'Eliminations and central costs' above.
Other costs, such as Group insurance and auditors' remuneration
which are incurred on a Group-wide basis are recharged by the head
office to segments on a reasonable and consistent basis for all
periods presented, and are included within segment results
above.
b) Other Income Statement segmental
information
Year
ended 30 June 2024
|
Brand Architekt
Brands
|
Innovaderma
Brands
|
Eliminations and Central
Costs
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Depreciation / impairment of
PPE
|
33
|
-
|
-
|
33
|
Amortisation / impairment of
intangibles *
|
79
|
-
|
975
|
1,054
|
|
|
|
Year
ended 30 June 2023
|
Brand Architekt
Brands
|
Innovaderma
Brands
|
Eliminations and Central
Costs
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
Depreciation
|
32
|
-
|
-
|
32
|
Amortisation/ impairment*
|
91
|
3,500
|
1,027
|
4,618
|
|
|
|
|
|
* Impairment losses of £Nil (2023:
£nil) in Central Costs is included in Exceptional Items -
Impairment of intangible assets
|
|
|
|
|
|
|
|
|
|
|
c) Principal measures of assets and
liabilities
The Groups assets and liabilities
are managed centrally by the CODM and consequently there is no
reconciliation between the Group's assets per the statement of
financial position and the segment assets.
d) Additional entity-wide
disclosures
The distribution of the Group's
external revenue by destination is shown below:
Geographical segments
|
|
Year ended
|
Year
ended
|
|
|
30 June
2024
|
30 June
2023
|
|
|
£'000
|
£'000
|
UK
|
|
13,290
|
15,781
|
Other European Union
countries
|
|
751
|
642
|
Rest of the World
|
|
2,986
|
3,662
|
|
|
17,027
|
20,085
|
In the year ended 30 June 2024, the
Group had two customers that exceeded 10% of total revenues, being
11.0% and 10.7% respectively. In the year ended 30 June 2023, the
Group had one customer that exceeded 10% of total revenues, being
13.7%. All of these customers are reported within the Brand
Architekts Brands segment. Revenue is recognised when goods are
despatched to the customer and the significant risks and rewards of
ownership to the customer have been transferred. Our policy
requires customers to pay us in accordance with agreed payment
terms. Depending on the geographical location, our settlement
terms are generally due within 30 or 60 days from the end of the
month of sale.
Note
3 Exceptional Items
Exceptional charges / (credits) from Continuing
Operations:
|
Year ended
|
Year ended
|
|
|
30 June
2024
|
30 June
2023
|
|
|
£'000
|
£'000
|
|
|
|
|
Exceptional items - Impairment of
intangible assets
|
|
-
|
3,500
|
|
|
|
|
Other exceptional items:
|
|
|
|
Restructuring costs
|
|
83
|
390
|
Legal costs
|
|
31
|
705
|
Other exceptional costs
|
|
19
|
(17)
|
Total exceptional items
|
133
|
4,578
|
Exceptional impairments of
intangible assets relates to the partial impairment of the
InnovaDerma brand of £nil (2023: £3.5m).
Restructuring costs of £0.08m (2023:
£0.4m) have been incurred following the acquisition of InnovaDerma
in 2022.
Legal costs of £0.03m (2023: £0.7m)
associated with the resolution of the claim with MR Haircare were
incurred in the year. There are no further costs connected with the
settlement agreement (2023: £425k).
Note
4 Loss before taxation
|
2024
|
2023
|
|
£'000
|
£'000
|
(a)
This is stated after charging/ (crediting)
|
|
|
Depreciation of property, plant and
equipment of purchased assets
|
33
|
32
|
|
|
|
Amortisation of intangible
assets
|
1,054
|
1,118
|
Foreign exchange (gains) /
losses
|
51
|
66
|
Amounts expensed for short term and
low value leases
|
56
|
56
|
|
|
|
(b)
Auditors' remuneration
|
|
|
Audit services:
|
|
|
Audit of the Company financial
statements
|
64
|
57
|
Audit of subsidiary
undertakings
|
44
|
32
|
Audit related services:
|
|
|
Interim review
|
3
|
3
|
Note 5 Taxation
|
|
2024
|
2023
|
(a)
Analysis of tax charge in the year
|
|
£'000
|
£'000
|
UK corporation
tax:
|
|
|
|
- on
profit for the year
|
|
-
|
-
|
-
adjustment in respect of previous years
|
|
5
|
-
|
Total current tax
credit
|
|
-
|
-
|
Deferred
tax:
|
|
-
|
-
|
-current
year (credit)/ charge
|
|
(61)
|
(188)
|
Total deferred tax
charge
|
|
(61)
|
(188)
|
Tax charge
|
|
(56)
|
(188)
|
(b)
Factors affecting total tax charge for the year
The tax assessed on the profit
before taxation for the year is at the standard rate of UK
corporation tax of 25.00% (2023: 20.50%). The differences are
reconciled below:
|
|
2024
|
2023
|
|
|
£'000
|
£'000
|
Loss
before taxation
|
|
(1,446)
|
(6,773)
|
Tax at the
applicable rate of 20.5.%
(2022: 19.00%)
|
|
(361)
|
(1,388)
|
Effect of:
|
|
|
|
Adjustment
in respect of previous years
|
|
5
|
-
|
Expenses
not deductible for tax purposes
|
|
162
|
792
|
Adjustment
to losses
|
|
-
|
15
|
Deferred
tax asset not recognised on taxable losses
|
|
134
|
494
|
Remeasurement of deferred tax for changes in tax rates
|
|
-
|
(44)
|
Other
timing differences
|
|
4
|
(57)
|
|
|
|
|
Actual tax
(credit)
|
|
(56)
|
(188)
|
Amount of tax charged
directly to equity
|
|
344
|
376
|
The group has tax losses of £13.8m
(2023: £12.9m) which have not been recognised as there is no
certainty that they can be utilised.
Note 6 Earnings per share
|
|
2024
|
2023
|
Basic and Diluted
|
|
|
|
Loss for
the year attributable to equity holders (£'000)
|
|
(1,456)
|
(6,588)
|
|
|
|
|
Basic
weighted average number of ordinary shares in issue during the
year
|
|
27,943,180
|
27,943,180
|
Diluted
number of shares
|
|
28,748,949
|
28,032,180
|
Basic loss per
share
|
|
(5.2)p
|
(23.5)p
|
Diluted loss per
share
|
|
(5.2)p
|
(23.5)p
|
Basic earnings per share has been
calculated by dividing the profit for each financial year by the
weighted average number of ordinary shares in issue at 30 June 2024
and 30 June 2023 respectively.
Note
7 Intangible assets
|
Software and
Trademarks
|
Brand Names
|
Customer
Relationships
|
Goodwill
|
Trade
marks
|
Total
|
GROUP
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Cost:
|
|
|
|
|
|
|
At June
2022
|
603
|
10,323
|
4,455
|
8,354
|
19
|
23,754
|
Additions
|
44
|
-
|
-
|
-
|
-
|
44
|
At June
2023
|
647
|
10,323
|
4,455
|
8,354
|
19
|
23,798
|
Additions
|
24
|
-
|
-
|
-
|
-
|
24
|
At June
2024
|
671
|
10,323
|
4,455
|
8,354
|
19
|
23,822
|
Amortisation:
|
|
|
|
|
|
|
At June
2022
|
471
|
3,024
|
1,386
|
-
|
3
|
4,884
|
Provided
during the year
|
85
|
466
|
561
|
-
|
6
|
1,118
|
Impairment
charge during the year
|
-
|
-
|
-
|
3,500
|
-
|
3,500
|
Disposals
|
-
|
-
|
-
|
(166)
|
-
|
(166)
|
At June
2023
|
556
|
3,490
|
1,947
|
3,334
|
9
|
9,336
|
Provided
during the year
|
69
|
322
|
653
|
-
|
10
|
1,054
|
At June
2024
|
625
|
3,812
|
2,600
|
3,334
|
19
|
10,390
|
Net book
value:
|
|
|
|
|
|
|
At June
2024
|
46
|
6,511
|
1,855
|
5,020
|
-
|
13,432
|
At June
2023
|
91
|
6,833
|
2,508
|
5,020
|
10
|
14,462
|
|
Brand Names
|
Customer
Relationships
|
Total
|
COMPANY
|
£'000
|
£'000
|
£'000
|
Cost:
|
|
|
|
At June
2022
|
3,624
|
480
|
4,104
|
At June
2023
|
3,624
|
480
|
4,104
|
At June
2024
|
3,624
|
480
|
4,104
|
Amortisation:
|
|
|
|
At June
2022
|
3,024
|
383
|
3,407
|
Provided
during the year
|
-
|
74
|
74
|
At June
2023
|
3,024
|
457
|
3,481
|
Provided
during the year
|
-
|
23
|
23
|
At June
2024
|
3,024
|
480
|
3,504
|
Net book
value:
|
|
|
|
At June
2024
|
600
|
-
|
600
|
At June
2023
|
600
|
23
|
623
|
Impairment
testing
Three Brands (Brand Architekts, Fish
and InnovaDerma) and associated goodwill have been tested for
impairment as they have indefinite useful lives. All the brands
gave a valuation in excess of their carrying values, and therefore
no impairment is required.
The recoverable amount of each brand
was determined based on the higher of value-in-use calculations or
fair value less costs to sell. The value-in-use calculations
covered underlying 1-2 year forecasts, followed by an extrapolation
of expected cash flows for the remaining useful life using growth
assumptions of 2%. Fair value less costs to sell was determined by
a review of historical acquisitions in the consumer goods market of
similar size and current market data to identify multiples that
have been paid.
The present value of the expected
cash flows is determined by applying a suitable discount rate for
current market assessments of the time value of money and risks
specific to the brand. The discount rate applied is 12.2% (2023:
8.1%), reflecting expected returns for AIM listed businesses as
well as the debt free capital structure of the Group.
Growth assumptions
Management have assumed a base case
growth rate of 2%, in line with wider industry forecasts, in the
calculations including into perpetuity.
Discount rates
The discount rates reflect
appropriate adjustments relating to market risk and specific risk
factors.
Cash flow assumptions
Management's key assumptions include
profit margins, based on past experience in this market. The
Group's management believes that this is the best available input
for forecasting this mature sector. The expectations included in
the workings are for increases in performance and profits being
made due to cost synergies from integration into the BAG group and
a focus on higher margin products.
Apart from the considerations in
determining the value-in-use of the brand described above,
management is not currently aware of any other probable changes
that would necessitate changes in its key estimates. The values of
the intangibles with indefinite useful lives for Brand Architekts
remains at £7,709,000 (comprising Goodwill of £2,618,000 and Brands
of £5,091,000), while the Fish brand net carry value is £600,000.
Goodwill held in relation to InnovaDerma was £2,402,000. The value
of the customer relationship intangibles for Brand Architekts are
£313,000. The values of the customer relationship and brand
intangibles for InnovaDerma are £1,397,000 and £964,000
respectively.
Sensitivity analysis
Impairment is assessed on the higher
of the value in use and fair value less costs to sell and as a
result the fair value has been used to assess the impairment. The
maximum amount that fair value less costs to sell would reduce by
before there is an impairment is £2,636k for Brand Architekts
goodwill and brand names and £1,282k for the Innovaderma group
goodwill.
Note 8 Notes to Cash Flow Statement
|
|
2024
|
2023
|
|
|
£'000
|
£'000
|
Decrease
in cash and cash equivalents
|
|
(1,214)
|
(3,170)
|
Change in
net cash
|
|
(1,214)
|
(3,170)
|
Opening
net cash
|
|
8,177
|
11,347
|
Closing
net cash
|
|
6,963
|
8,177
|
|
|
|
|
|
|
|
(b)
Analysis of net cash:
|
|
Closing
2023
|
Cash
Flow
|
Closing
2024
|
|
|
|
£'000
|
£'000
|
£'000
|
|
Cash at
bank and in hand
|
|
8,177
|
(1,214)
|
6,963
|
|
|
|
8,177
|
(1,214)
|
6,963
|
|
|
|
|
|
|
|
|
|
|
|